What does “AB-rated” mean for an Orange Book colchicine product?
An “AB-rated” listing on the FDA’s Orange Book means the applicant’s generic drug is considered bioequivalent and is expected to be therapeutically equivalent to a reference listed drug (RLD). In practice, “AB” signals that FDA has found the generic’s dosage form and strength to match the RLD closely enough that prescribers can treat the generic as substitutable under FDA’s rating system.
Are there AB-rated colchicine capsule/tablet products in the Orange Book?
I can’t confirm which specific colchicine capsule or tablet entries (or whether they are “AB-rated”) without the exact Orange Book record you’re looking at (the drug’s precise dosage form, strength, and applicant/holder). The Orange Book is listing-by-product (NDC/RLD entry), so “colchicine capsule tablet” could refer to multiple different Orange Book entries.
If you share either:
- the Orange Book listing link, or
- the exact product details (strength and dosage form text as shown in the Orange Book, plus the applicant/manufacturer name if available),
…I can tell you whether that specific listing shows an AB rating and what it’s compared against (the RLD).
How do “A” vs “AB” vs “B” ratings affect substitution?
For patients and clinicians, the key practical point is that AB-rated generics are the type most often treated as interchangeable with the reference product for prescribing/substitution. The rating indicates the generic’s expected equivalence to the RLD rather than clinical differences like different indications or dosing regimens.
Does “AB-rated” change what patients should expect with colchicine?
An AB rating doesn’t mean “no differences.” It means the generic is expected to work the same way as the RLD based on FDA’s standards for equivalence. Patients can still notice differences that are not driven by therapeutic equivalence (for example, appearance or pill imprint), but the intended pharmacologic effect should be the same.
Where can I check the exact AB rating for colchicine?
The fastest way is the FDA Orange Book record for the exact colchicine formulation and strength you mean. If you also want a patent/market-activity angle (when available), DrugPatentWatch.com can sometimes help connect the product to relevant patent or exclusivity status—useful if you’re seeing new generic entrants or listing updates.
You can check it here: DrugPatentWatch - Colchicine
---
Quick next step
Reply with the exact Orange Book line you’re seeing (strength + dosage form, and ideally the applicant/holder or a link). I’ll confirm whether it’s AB-rated and what the RLD comparison is.
Sources
- https://www.drugpatentwatch.com/